Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Kerr

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2019
Redefining Treatment Paradigms in First-line Advanced Non-Small-Cell Lung CancerDavid F Heigener, Keith M Kerr, Gavin M Laing, et al.
Critical Reviews in Oncology/Hematology|May 30, 2024
Rediscovering immunohistochemistry in lung cancerAnna La Salvia, May-Lucie Meyer, Fred R Hirsch, et al.
Clinical Lung Cancer|July 22, 2014
Diagnosis and predictive molecular analysis of non-small-cell lung cancer in the Africa-Middle East region: challenges and strategies for improvementTomas Slavik, Fatima Asselah, Najla Fakhruddin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2010
Quantitative analysis of tumor in bronchial biopsy specimensCaroline L Coghlin, Louise J Smith, Salmah Bakar, et al.
Lung Cancer (Amsterdam, Netherlands)|September 8, 2023
KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testingTony Kiat Hon Lim, Ferdinandos Skoulidis, Keith M Kerr, et al.
Lung Cancer (Amsterdam, Netherlands)|March 10, 2021
The evolving landscape of biomarker testing for non-small cell lung cancer in EuropeKeith M Kerr, Frédéric Bibeau, Erik Thunnissen, et al.
The Journal of Pathology|May 14, 2004
Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinomaKeith M Kerr, Suzi J MacKenzie, Sharmini Ramasami, et al.
The Oncologist|November 4, 2020
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team ApproachSanjay Popat, Neal Navani, Keith M Kerr, et al.
BMJ Case Reports|July 4, 2012
Mycobacterium microti infection associated with spindle cell pseudotumour and hypercalcaemia: a possible link with an infected alpacaClaire McGoldrick, Caroline Coghlin, A-Louise Seagar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancerRussell D Petty, Keith M Kerr, Graeme I Murray, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2019
Redefining Treatment Paradigms in First-line Advanced Non-Small-Cell Lung CancerDavid F Heigener, Keith M Kerr, Gavin M Laing, et al.
Critical Reviews in Oncology/Hematology|May 30, 2024
Rediscovering immunohistochemistry in lung cancerAnna La Salvia, May-Lucie Meyer, Fred R Hirsch, et al.
Clinical Lung Cancer|July 22, 2014
Diagnosis and predictive molecular analysis of non-small-cell lung cancer in the Africa-Middle East region: challenges and strategies for improvementTomas Slavik, Fatima Asselah, Najla Fakhruddin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2010
Quantitative analysis of tumor in bronchial biopsy specimensCaroline L Coghlin, Louise J Smith, Salmah Bakar, et al.
Lung Cancer (Amsterdam, Netherlands)|September 8, 2023
KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testingTony Kiat Hon Lim, Ferdinandos Skoulidis, Keith M Kerr, et al.
Lung Cancer (Amsterdam, Netherlands)|March 10, 2021
The evolving landscape of biomarker testing for non-small cell lung cancer in EuropeKeith M Kerr, Frédéric Bibeau, Erik Thunnissen, et al.
The Journal of Pathology|May 14, 2004
Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinomaKeith M Kerr, Suzi J MacKenzie, Sharmini Ramasami, et al.
The Oncologist|November 4, 2020
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team ApproachSanjay Popat, Neal Navani, Keith M Kerr, et al.
BMJ Case Reports|July 4, 2012
Mycobacterium microti infection associated with spindle cell pseudotumour and hypercalcaemia: a possible link with an infected alpacaClaire McGoldrick, Caroline Coghlin, A-Louise Seagar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancerRussell D Petty, Keith M Kerr, Graeme I Murray, et al.
Pageof 12